No Data
日光控股:董事會會議日期
Futu NewsApr 26 07:24 ET · Announcements
Bawang International Swings to Profit in 2023
Bawang International (Group) Holding (HKG:1338) reported profit attributable to owners of 13.6 million yuan for the year ended Dec. 31, 2023, compared with a loss of 19.3 million yuan in the previous
MT NewswiresApr 24 21:17 ET
霸王集團:二零二三年年報
Futu NewsApr 24 18:29 ET · Announcements
中國金典集團:年度報告 2023
Futu NewsApr 23 06:10 ET · Announcements
Pioneer Pharmaceutical Biotech announced that the placement agreement has expired and that the placement matters will not be carried out
Pilot Pharmaceutical Biotechnology (00399) issued an announcement. Since the prerequisites contained in the placement agreement were not fully reached or satisfied before April 18, 2024 (that is, the final deadline of the placement agreement), the placement agreement has expired and the placement matters will not proceed. All rights, obligations and liabilities of the contracting party to the placement agreement will cease and end, and the contracting party will not file any claims against the other party, except for any prior breach of the placement agreement before the termination of the placement agreement. The announcement stated that the expiration of the placement agreement will not have any significant adverse impact on the company's current operations and financial situation.
新浪港股Apr 21 20:42 ET
Pioneer Pharmaceutical Biotechnology (00399.HK): The placement agreement has expired
Gelonghui, April 19 | Pilot Pharmaceutical Biotechnology (00399.HK) announced that since the prerequisites contained in the placement agreement were not fully reached or satisfied before April 18, 2024, the placement agreement has expired and the placement matters will not proceed.
Gelonghui FinanceApr 19 08:37 ET